We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01462214
Recruitment Status : Completed
First Posted : October 31, 2011
Last Update Posted : May 10, 2017
Sponsor:
Collaborators:
Dutch Cancer Society
Novartis
Information provided by (Responsible Party):
Hans J. van der Vliet, MD, PhD, Amsterdam UMC, location VUmc